Categories: The Charlton Centre

News From the International Menopause Society Meeting in Vancouver

Carolyn Whiskin and Kerry Roberts, two of our pharmacists at Charlton, have just returned from the International Menopause Society Meeting in Vancouver. They are both Certified Menopause Practitioners and were very proud to be attending, as this is the first time this meeting has been hosted in Canada. Presenters from around the world shared their research and many new treatments not yet available in Canada were discussed.

One of the first areas discussed was the amount of menopausal hormone replacement prescribed to patients. Although up to 46% of women go to their health professional with menopausal complaints, only 10% or women receive hormone replacement therapy. This is in part due to the lack of awareness surrounding the most recent evidence: that the benefits of hormone replacement outweigh the low level of risk. IMPART is an online series of educational modules for health professionals designed as a refresher course in the treatment of peri-menopausal and menopausal women. It was launched at the conference and is available through the International Menopause Society’s website at no charge. Experts from around the world wrote the content which will updated on a regular basis. We invite you to share this information with your healthcare practitioners.

We will be sharing some of the information learned at this meeting over the next few weeks.


Carolyn Whiskin is the Pharmacy Manager for Charlton Health.  Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Recent Posts

Saphnelo for Lupus

Saphnelo (anifrolumab) is a one-of-a-kind therapy by AstraZeneca for the treatment of moderate to severe…

3 weeks ago

A New Treatment Option for Alopecia Areata

On December 4, 2023, Health Canada approved Pfizer’s Litfulo (ritlecitinib). Litfulo is a once-daily oral…

1 month ago

Infliximab Now Available As An Injection for Crohn’s and Ulcerative Colitis Patients

Infliximab is a protein-based medication referred to as a biologic that treats many immune-mediated conditions. …

2 months ago

A New Treatment For Ulcerative Colitis

On October 3rd, 2023, Health Canada approved Eli Lilly’s newest biologic for the treatment of…

2 months ago

Show Love to your Heart

As February is heart month, today is an excellent occasion to really show why we love our hearts and…

3 months ago

Charlton Infusion Clinic Expansion

To better serve our Hamilton and area patients, we have expanded and moved our Stoney…

3 months ago